Details for New Drug Application (NDA): 086188
✉ Email this page to a colleague
NDA 086188 describes GERIMAL, which is a drug marketed by Watson Labs and is included in three NDAs. Additional details are available on the GERIMAL profile page.
The generic ingredient in GERIMAL is ergoloid mesylates. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ergoloid mesylates profile page.
The generic ingredient in GERIMAL is ergoloid mesylates. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ergoloid mesylates profile page.
Summary for 086188
| Tradename: | GERIMAL |
| Applicant: | Watson Labs |
| Ingredient: | ergoloid mesylates |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 086188
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;SUBLINGUAL | Strength | 1MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
